Antiproliferative and proapoptotic actions of okra pectin on B16F10 melanoma cells

Muriel Vayssade1, Nipaporn Sengkhamparn, René Verhoef

  • 1UMR CNRS 6600, Université de Technologie de Compiègne, France.

Phytotherapy Research : PTR
|December 17, 2009
PubMed

Insights

Okra rhamnogalacturonan (RG-I) inhibits melanoma cell growth and survival. This natural compound induces apoptosis and alters cell adhesion molecules, suggesting potential for novel melanoma therapies.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Metastatic melanoma exhibits abnormal cell proliferation and apoptosis.
  • Investigating natural compounds for anti-cancer properties is crucial.

Purpose of the Study:

  • To evaluate the effect of okra pectic rhamnogalacturonan (okra RG-I) on melanoma cell growth and survival.
  • To explore the potential of okra RG-I as a therapeutic agent against melanoma.

Main Methods:

  • In vitro study using 2D and 3D cultures of B16F10 mouse melanoma cells.
  • Analysis of cell morphology, proliferation, apoptosis, cell cycle, and adhesion molecule expression.
  • Immunostaining and western blotting to detect galectin-3 (Gal-3) protein.

Main Results:

  • Okra RG-I significantly reduced melanoma cell proliferation in both 2D and 3D cultures.
  • Cell cycle arrest at G2/M phase and induced apoptosis were observed, particularly in 3D cultures.
  • Alterations in adhesion molecules (decreased N-cadherin and alpha5 integrin) and increased cell membrane Gal-3 expression were noted.

Conclusions:

  • Okra RG-I demonstrates anti-proliferative and pro-apoptotic effects on melanoma cells.
  • The interaction between okra RG-I and Gal-3 may mediate its anti-melanoma activity.
  • Further research is warranted to elucidate the precise mechanisms for potential therapeutic applications.